GBIO vs XLK
Generation Bio Co (GBIO) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
Generation Bio Co (GBIO) is a biotechnology company listed on US.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported GBIO revenue for 2024-12-31 was $19.9M. Net income was -$131.7M. Revenue was up 236.9% from 2023-12-31 to 2024-12-31. GBIO currently screens at market cap $25.4M.
XLK does not have a complete income-statement cache yet.
GBIO currently screens at market cap $25.4M. XLK currently screens at market cap $0.
Not investment advice. Open the GBIO and XLK stock pages for the full models.
Not investment advice.